Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Borja de Miguel"'
Autor:
Rafael San-Juan, Mario Fernández-Ruiz, Francisco López-Medrano, Octavio Carretero, Antonio Lalueza, Guillermo Maestro de la Calle, María Asunción Pérez-Jacoiste Asín, Héctor Bueno, José Manuel Caro-Teller, Mercedes Catalán, Cristina de la Calle, Rocío García-García, Carlos Gómez, Rocío Laguna-Goya, Manuel Lizasoáin, Joaquín Martínez-López, Julia Origüen, Ángel Sevillano, Eduardo Gutiérrez, Borja de Miguel, Fernando Aguilar, Patricia Parra, Mar Ripoll, Tamara Ruiz-Merlo, Hernando Trujillo, José Luis Pablos, Estela Paz-Artal, Carlos Lumbreras, José María Aguado
Publikováno v:
International Journal of Infectious Diseases, Vol 117, Iss , Pp 56-64 (2022)
Background: Controversy remains about the efficacy of tocilizumab (TCZ) for the treatment of severe COVID-19. We aimed to analyze the profile of TCZ-respondent patients. Methods: We retrospectively analyzed a cohort of patients with severe COVID-19 w
Externí odkaz:
https://doaj.org/article/ae0cc7dca8e644fdbf6f2ddb513e65e0
Autor:
Cristina de la Calle, Francisco López-Medrano, José Luis Pablos, Jaime Lora-Tamayo, Guillermo Maestro-de la Calle, Marcos Sánchez-Fernández, Mario Fernández-Ruiz, María Asunción Pérez-Jacoiste Asín, José Manuel Caro-Teller, Rocío García-García, Mercedes Catalán, Joaquín Martínez-López, Ángel Sevillano, Julia Origüen, Mar Ripoll, Rafael San Juan, Antonio Lalueza, Borja de Miguel, Octavio Carretero, Fernando Aguilar, Carlos Gómez, Estela Paz-Artal, Héctor Bueno, Carlos Lumbreras, José María Aguado
Publikováno v:
International Journal of Infectious Diseases, Vol 105, Iss , Pp 319-325 (2021)
Objectives: A subgroup of patients with SARS-CoV-2 infection was thought to have developed cytokine release syndrome and were treated with tocilizumab; however, a significant percentage of patients evolved. This study aimed to determine the usefulnes
Externí odkaz:
https://doaj.org/article/2543e0c85e56417782de86588ea94481
Autor:
Francisco López-Medrano, María Asunción Pérez-Jacoiste Asín, Mario Fernández-Ruiz, Octavio Carretero, Antonio Lalueza, Guillermo Maestro de la Calle, José Manuel Caro, Cristina de la Calle, Mercedes Catalán, Rocío García-García, Joaquín Martínez-López, Julia Origüen, Mar Ripoll, Rafael San Juan, Hernando Trujillo, Ángel Sevillano, Eduardo Gutiérrez, Borja de Miguel, Fernando Aguilar, Carlos Gómez, José Tiago Silva, Daniel García-Ruiz de Morales, Miguel Saro-Buendía, Ángel Marrero-Sánchez, Guillermo Chiara-Graciani, Héctor Bueno, Estela Paz-Artal, Carlos Lumbreras, José L. Pablos, José María Aguado
Publikováno v:
International Journal of Infectious Diseases, Vol 105, Iss , Pp 487-494 (2021)
Background: The role of combination immunomodulatory therapy with systemic corticosteroids and tocilizumab (TCZ) for aged patients with COVID-19-associated cytokine release syndrome remains unclear. Methods: A retrospective single-center study was co
Externí odkaz:
https://doaj.org/article/c351e917b2c2412f8a82e011249ce440
Autor:
David Balaz, Philip Erick Wikman-Jorgensen, Vicente Giner Galvañ, Manuel Rubio-Rivas, Borja de Miguel Campo, Mariam Noureddine López, Juan Francisco López Caleya, Ricardo Gómez Huelgas, Paula María Pesqueira Fontán, Manuel Méndez Bailón, Mar Fernández-Garcés, Ana Fernández Cruz, Gema María García García, Nicolás Rhyman, Luis Corral-Gudino, Aquiles Lozano Rodríguez-Mancheño, María Navarro De La Chica, Andrea Torregrosa García, José Nicolás Alcalá, Pablo Díaz Jiménez, Leticia Esther Royo Trallero, Pere Comas Casanova, Jesús Millán Núñez-Cortés, José-Manuel Casas-Rojo, on behalf of the SEMI-COVID-19 Network
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 19, p 4610 (2021)
Objectives: Since the results of the RECOVERY trial, WHO recommendations about the use of corticosteroids (CTs) in COVID-19 have changed. The aim of the study is to analyse the evolutive use of CTs in Spain during the pandemic to assess the potential
Externí odkaz:
https://doaj.org/article/edb65a6bd4e048e18cf71e2055f5e747
Autor:
Estela Paz-Artal, Borja de Miguel, Octavio Carretero, Guillermo Maestro de la Calle, Carlos Mario Gómez Gómez, Mar Ripoll, Rocío García-García, Marcos Sánchez-Fernández, Rafael San Juan, Antonio Lalueza, Carlos Lumbreras, José L. Pablos, José María Aguado, Jaime Lora-Tamayo, Mario Fernández-Ruiz, Joaquin Martinez-Lopez, Cristina de la Calle, Fernando Aguilar, José Manuel Caro-Teller, Angel Sevillano, Julia Origüen, María Asunción Pérez-Jacoiste Asín, Mercedes Catalán, Francisco López-Medrano, Héctor Bueno
Publikováno v:
International Journal of Infectious Diseases, Vol 105, Iss, Pp 319-325 (2021)
International Journal of Infectious Diseases
Repisalud
Instituto de Salud Carlos III (ISCIII)
International Journal of Infectious Diseases
Repisalud
Instituto de Salud Carlos III (ISCIII)
A subgroup of patients with SARS-CoV-2 infection was thought to have developed cytokine release syndrome and were treated with tocilizumab; however, a significant percentage of patients evolved. This study aimed to determine the usefulness of anakinr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::777dcb7922d1a43407a8b1df4cc67853
https://hdl.handle.net/20.500.12105/13431
https://hdl.handle.net/20.500.12105/13431
Autor:
Octavio Carretero, Carlos Lage Gómez, Borja de Miguel, Héctor Bueno, Eduardo Gutiérrez, Joaquin Martinez-Lopez, Julia Origüen, Rafael San Juan, José L. Pablos, Guillermo Chiara-Graciani, José María Aguado, José Tiago Silva, Mercedes Catalán, Hernando Trujillo, Daniel García-Ruiz de Morales, Cristina de la Calle, María Asunción Pérez-Jacoiste Asín, Rocío García-García, Carlos Lumbreras, José Manuel Caro, Antonio Lalueza, Mar Ripoll, Miguel Saro-Buendía, Guillermo Maestro de la Calle, Estela Paz-Artal, Angel Sevillano, Fernando Aguilar, Mario Fernández-Ruiz, Ángel Marrero-Sánchez, Francisco López-Medrano
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 105, Iss, Pp 487-494 (2021)
International Journal of Infectious Diseases, Vol 105, Iss, Pp 487-494 (2021)
BackgroundThe role of combination immunomodulatory therapy with systemic corticosteroids and tocilizumab (TCZ) for aged patients with COVID-19-associated cytokine release syndrome remains unclear.MethodsWe conducted a retrospective single-center stud
Autor:
Carlos Lumbreras, Jaime Lora-Tamayo, Irene Losada, Octavio Carretero, José María Aguado, Rafael San Juan, Mikel Mancheño-Losa, Estibaliz Arrieta, Antonio Lalueza, A. García-Reyne, Guillermo Maestro de la Calle, Mario Fernández-Ruiz, Cristina de la Calle, Raquel Díaz-Simón, Borja de Miguel, Francisco López-Medrano
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases
The aim of our study was to elucidate if SARS-CoV-2 viral load on admission, measured by real-time reverse transcriptase–polymerase chain reaction (rRT-PCR) cycle threshold (Ct) value on nasopharyngeal samples, was a marker of disease severity. All
Autor:
Antonio, Lalueza, Jaime, Lora-Tamayo, Guillermo, Maestro-de la Calle, Dolores, Folgueira, Estíbaliz, Arrieta, Borja, de Miguel-Campo, Raquel, Díaz-Simón, David, Lora, Cristina, de la Calle, Mikel, Mancheño-Losa, Álvaro, Marchán-López, Ana, García-Reyne, Mario, Fernández-Ruiz, Javier, Sayas-Catalán, Antonio, Serrano, Cecilia, Cueto-Felgueroso, Rafael, San Juan, Rocío, García-García, Mercedes, Catalán, Victoria, Villena, José María, Aguado, Carlos, Lumbreras, María José, Zamorro-Lorenci
Publikováno v:
Internal and Emergency Medicine
Coronavirus Disease 2019 (COVID-19) pandemic has implacably stricken on the wellness of many countries and their health-care systems. The aim of the present study is to analyze the clinical characteristics of the initial wave of patients with COVID-1